BUY Titan Company Ltd. — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)30 Dec 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·20 Jul · 2d ago
ICRA has reaffirmed ratings for Titan Company Ltd's long-term fixed deposit programme, working capital facilities, and term loans. The rating for the fixed deposit programme was assigned for a reduced
BSE · Company Update·7 Jul · 2w ago
8 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·7 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Titan Company
- BUY — Jefferies India6 Nov 2026 · ~1 year · target ₹6,000 · Active
- BUY — Prakash Gaba6 Nov 2026 · Next day · target ₹5,100 · Active
- BUY — Shivangi Sarda, Motilal Oswal6 Nov 2026 · Same day · target ₹5,100 · Expired
- BUY — HSBC Securities6 Nov 2026 · ~1 year · target ₹5,610 · Active
- BUY — Prakash Gaba6 Nov 2026 · Same day · target ₹5,000 · Target hit
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

